Wednesday, December 14, 2016

CPIC Guideline Update: CYP2D6, CYP2C19 and tricyclic antidepressants (TCAs)

›
The 2016 update of the guidelines by the Clinical Pharmacogenetics Implementation Consortium ( CPIC ) regarding the use of pharmacogenetic ...
Thursday, December 8, 2016

New CPIC Guideline - CYP2C19 and voriconazole

›
Guidelines by the Clinical Pharmacogenetics Implementation Consortium ( CPIC ) regarding the use of pharmacogenetic tests of CYP2C19 for vor...
Monday, December 5, 2016

New and Updated PMDA label translations now available

›
New translations of package inserts from the Pharmaceutical and Medical Devices Agency (PMDA), Japan, as well as updated translations of exi...
Friday, November 18, 2016

Very Important Pharmacogene (VIP) summary for MT-RNR1 published in Pharmacogenetics and Genomics

›
The PharmGKB review of the MT-RNR1 gene has been published in the December issue of Pharmacogenetics and Genomics . MT-RNR1  is a mitochondr...
Wednesday, October 26, 2016

Upcoming change to user accounts

›
We will be making a small change to user accounts this weekend that should make our users’ lives a little easier. Registered PharmGKB users ...
Tuesday, September 27, 2016

Coverage of PharmCAT in GenomeWeb

›
In April 2016 and August 2016 we blogged about the development of PharmCAT and its presentation at the  American Society of Human Genetics...
Monday, September 26, 2016

Response to the American Academy of Pediatrics statement on codeine: let's consider CYP2D6

›
The American Academy of Pediatrics (AAP) issued a statement last Tuesday that codeine should not be used in children. As discussed in the a...